TROPHIMMUN: Avelumab for gestational trophoblastic tumours resistant to monochemotherapy

1 Views

07/14/23

Dr Benoit You talks to ecancer in an online interview about the TROPHIMMUN phase II trial.

The TROPHIMMUN trial looks at avelumab in patients with gestational trophoblastic tumours resistant to monochemotherapy.

He outlines the background, trial design, results and toxicity profile.

Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php